Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00593268 · ClinicalTrials.gov registry record

Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage

A clinical trial of Subarachnoid Hemorrhage, sponsored by Vanderbilt University Medical Center.

Active
Registry status
150
Enrollment target
1
Study location

NCT00593268: Active study of Subarachnoid Hemorrhage, sponsored by Vanderbilt University Medical Center.

NCT00593268 is a study of Subarachnoid Hemorrhage that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 150 participants, below the 3,581-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00593268, a study of Subarachnoid Hemorrhage, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

In this project we are collecting cerebrospinal fluid and blood from patients at Vanderbilt Medical Center who have a subarachnoid hemorrhage which has followed the rupture of a brain aneurysm. We then propose to study the cerebrospinal fluid using a novel microscopic laser directed mass spectrometric analysis (MALDI) available at Vanderbilt. The cerebrospinal fluid and blood will then be analysed for different biological markers, protein expression and gene expression. These markers will then be statistically correlated with clinical data including prediction of vasospasm, time to vasospasm and response to standard therapy.

Primary Outcome

Correlation of blood biological markers and clinical outcomes of cerebral vasospasm

Conditions Studied

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center, Department of Neurological Surgery - Nashville

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2004-06
Est. Completion 2028-12

What the registry record for NCT00593268 still lists

NCT00593268 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 3,581-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 0 interventions.

NCT00593268 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT00593268 about?

NCT00593268 is a clinical study titled "Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage". In this project we are collecting cerebrospinal fluid and blood from patients at Vanderbilt Medical Center who have a subarachnoid hemorrhage which has followed the rupture of a brain aneurysm. We then propose to study the cerebrospinal fluid using a novel microscopic laser directed mass spectrometr...

What is the current status of trial NCT00593268?

This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2004-06. Estimated completion is 2028-12.

What conditions does trial NCT00593268 study?

This clinical trial studies the following conditions: Subarachnoid Hemorrhage.

Who is sponsoring clinical trial NCT00593268?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00593268 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Subarachnoid Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00593268's enrollment target sits among peer trials

150 9th of 21 higher than 13 of 21 other Subarachnoid Hemorrhage trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Subarachnoid Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00593268, the US trial registry maintained by the National Library of Medicine. NCT00593268 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.